4//SEC Filing
Cherevka Holli 4
Accession 0001415889-21-002667
CIK 0001411906other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 3:45 PM ET
Size
8.8 KB
Accession
0001415889-21-002667
Insider Transaction Report
Form 4
Cherevka Holli
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-21$0.51/sh+2,603$1,328→ 2,603 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−2,603→ 152,766 totalExercise: $0.51Exp: 2029-09-16→ Common Stock (2,603 underlying) - Sale
Common Stock
2021-05-21$2.00/sh−2,603$5,206→ 0 total
Footnotes (2)
- [F1]The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 12, 2021.
- [F2]Options were granted and previously reported on a Form 4 filed on September 18, 2019, where 50% of the options awarded vested and became exercisable on the grant date of September 16, 2019 and the other 50% of the options awarded vested and became exercisable on the first anniversary of the grant date.
Documents
Issuer
Ampio Pharmaceuticals, Inc.
CIK 0001411906
Entity typeother
Related Parties
1- filerCIK 0001717673
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 3:45 PM ET
- Size
- 8.8 KB